ARCHIVES

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Hew Approves Patent Request From U. Arizona; Califano Still Pondering Bioassay Program Fate

September 1, 1978

New NCI Director Varmus “Glad To Be Back,” Says Goal Is To Control Cancer Through Science

July 16, 2010

Komen Foundation Calls For Review Of Action Plan’s Goals

October 24, 1996

Other Contract Concepts Approved By DCE Board

March 10, 1989

Burton’s Clinic Reported Operating In Spite of Closure

December 13, 1985

NCI Stops Trial Of Screening In Men To Add Women

November 2, 1990